Challenges to the biomedical model: Are actions of patients almost always as important as actions of health professionals in long-term outcomes of chronic diseases?

Advances in Mind-Body Medicine

Volumn 16, Issue 4, 2000, Pages 287-294

  Pincus, T ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOFIBRATE; PROPRANOLOL;

BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER; CHRONIC DISEASE; CLINICAL OBSERVATION; CLINICAL TRIAL; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEART DISEASE; HUMAN; MEDICAL EDUCATION; MEDICAL SERVICE; MORTALITY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PROGNOSIS; RISK FACTOR; SOCIOECONOMICS; TREATMENT OUTCOME;

CHRONIC DISEASE; HUMANS; MOTIVATION; NEOPLASM METASTASIS; PATIENT CARE TEAM; SICK ROLE; TREATMENT OUTCOME;

EID: 0033755192     PISSN: 07419783     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (71)

1. Psychology of the exceptional cancer patient: A description of patients who outlive predicted live expectancies
2. Social class, life expectancy and overall mortality
3. Social class and the major cardiovascular disease
4. The role of socioeconomic factors in the survival of patients with colorectal cancer in Saarland/Germany
5. Formal education and five-year mortality in rheumatoid arthritis: Mediation by helplessness scale scores
6. The sense of coherence scale in rheumatoid arthritis: Associations with functional status and perceived learned helplessness
7. Unraveling the ball of string: Reality, paradigms, and the study of alternative medicine
8. Bias in treatment assignment in controlled clinical trials
9. The epidemiologic importance of psychosocial factors in longevity
10. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project
11. Association of psychological self-regulation with longer survival in patients with metastatic cancer
12. Chemotherapy of pulmonary tuberculosis in young adults: An analysis of the combined results of three medical research council trials
13. Myocardial infarction and coronary death among women: Psychosocial predictors from a 20-year follow-up of women in the Framingham Study
14. The need for a new medical model: A challenge for biomedicine
15. Malignant melanoma. Effects of an early structured psychiatric intervention, coping and affective state on recurrence and survival 6 years later
16. An additional basic science for clinical medicine: II. The limitations of randomized trials
17. Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials
18. Surrogate end points in clinical trials: Are we being misled?
19. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial: Survey of 71 'negative' trials
20. The randomized clinical trial as an obstacle to clinical research
21. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis
22. Educational status and active life expectancy among older blacks and whites
23. Determining optimal therapy-randomized trials in individual patients
24. Are the results of controlled clinical trials and observational studies of second line therapy in rheumatoid arthritis valid and generalizable as measures of rheumatoid arthritis outcome: Analysis of 122 studies
25. The sense of coherence questionnaire in patients with rheumatic disorders
26. The relationship of psychosocial factors to coronary heart disease in the Framingham study. III. Eight-year incidence of coronary heart disease
27. The 'excellence' deception in medicine
28. Social environment and cancer mortality in men
29. Social connections and mortality from all causes and from cardiovascular disease: Prospective evidence from eastern Finland
30. Commentary: What can we learn from studies of occupational class and cardiovascular disease?
31. Mortality rates and risk factors for coronary disease in blacks as compared with white men and women
32. Social class and coronary heart disease: A sociological assessment of the medical literature
33. Arthritis self-management studies: A twelve-year review
34. Determinants of late stage diagnosis of breast and cervical cancer: The impact of age, race, social class, and hospital type
35. Stress, social and cultural variations in heat disease
36. Explanations for social inequalities in health
37. Employment grade and coronary heart disease in British civil servants
38. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial
39. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986
40. Formal educational level - A marker for the importance of behavioral variables in the pathogenesis, morbidity, and mortality of most diseases?
41. Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trials
42. The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis
43. Limitations of randomized controlled clinical trials to recognize possible advantages of combination therapies in rheumatic diseases
44. Analyzing long-term outcomes of clinical care without randomized controlled clinical trials: The consecutive patient questionnaire database
45. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures
46. Associations of low formal education level and poor health status: Behavioral, in addition to demographic and medical, explanations?
47. What explains the association between socioeconomic status and health: Primarily medical access or mind-body variables?
48. Most chronic diseases are reported more frequently by individuals with fewer than 12 years of formal education in the age 1864 United States population
49. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
50. Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis
51. What is the best source of useful data on the treatment of rheumatoid arthritis: Clinical trials, clinical observations, or clinical protocols?
52. Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: Some explanations and suggestions for future studies
53. Treatment of rheumatoid arthritis: Challenges to traditional paradigms
54. Coronary heart disease in the Western Collaborative Group study: Final follow-up experience of 8-1/2 years
55. Can overall results of clinical trials be applied to all patients?
56. Psychosocial variables associated with the exceptional survival of patients with advanced malignant disease
57. Psychosocial influences on mortality of patients with coronary heart disease
58. Education psychosocial stress and sudden cardiac death
59. Psychosocial influences on mortality after myocardial infarction
60. The competing objectives of randomized trials
61. Controversy in counting and attributing events in clinical trials
62. Effect of psychosocial treatment of survival patients with metastatic breast cancer
63. Functional status and well-being of patients with chronic conditions: Results from the Medical Outcomes Study
64. Relation of education to sudden death after myocardial infarction
65. Prognostic importance of somatic and psychosocial variables after a first myocardial infarction
66. Listening to the patient: A practical guide to self-report questionnaires in clinical care